Instalift Facial Treatment
Silhouette InstaLift is a minimally-invasive method to lift deep layers of facial skin as well as increase and restore volume to the midface and cheek area. FDA-cleared in April 2015, Silhouette InstaLift delivers long lasting results without surgery and complements other aesthetic treatments Dr. Day may recommend as part of your bespoke cosmetic regimen. Sagging facial skin is one of the major contributors to an aged and tired appearance. Dr. Day and her associates will use Silhouette InstaLift to enhance the contours of your face. This lifts the deeper layers of your skin using special suture threads carefully placed under the skin, leading to a more youthful look.
During the in-office procedure, Dr. Day will begin by marking the areas of the face. She will then gently inject a local anesthetic at the sites of entry and exit of the sutures before guiding the delivery needle through and under the skin to deliver the threads at each bi-directional exit point. The sutures have bidirectional absorbable cones that hold them in place. The treatment is well tolerated by patients and typically takes about 45 minutes.
If you seek to reveal your healthiest, smoothest skin with fewer sagging and wrinkles, InstaLift may be ideal. InstaLift repositions the underlying layers of the skin with patented, bidirectional cones. As the InstaLift sutures and cones are resorbed, they stimulate collagen renewal, which helps increase and restore volume for natural-looking and long-lasting results! Post treatment, patients notice the effects of increased collagen and elastin and note that their all around skin texture is vastly improved.
We pride ourselves on providing personalized results for all of our patients. Schedule a consultation to discuss your goals with Dr. Day and discover if InstaLift is right for you!
Estrogen Study
This study is being done to see whether applying a cream with estradiol (a form of estrogen) to the face can improve overall skin quality and help reduce fine lines and wrinkles in peri- and post-menopausal women, and how this relates to epigenetic changes in the skin. A part of the study will also include applying an extra rapamycin analog cream to the face, which is also believed to improve overall skin quality and help reduce fine lines and wrinkles.
WHY THIS MATTERS
Skin aging in peri- and post-menopausal women is deeply tied to hormonal shifts. This study explores whether topical estradiol can turn back the clock – cellularly.
Eligibility
You MAY qualify if you can answer YES to all:
I am a healthy female (peri or menopausal) between the ages of 40 and 65.
I have not had any cosmetic facial treatments in the last 1-3 months.
I have not had any GLP-1 treatments in the last 6 months.
Study Design and Duration
The study includes daily evening application of study cream for 12 weeks, followed by 4 weeks with no test product use. In total, the study will last 16 weeks or approximately 4 months.
Topical Scalp Serum Containing RLX‑201 in Subjects With Mild‑to‑Moderate Hair Thinning
Purpose of the Study
The purpose of this study is to evaluate the safety, tolerability, and effectiveness of a scalp serum containing RLX‑201 when applied once daily for 20 weeks in men and women with mild‑to‑moderate hair thinning. The study will assess changes in hair density, hair thickness, and overall scalp health using clinical evaluations, imaging tools, and participant self‑assessments.
Eligibility
You MAY qualify if you can answer YES to all:
I am a healthy male or female between the ages of 30 and 60.
Self‑perceived mild‑to‑moderate hair thinning.
I have NOT used minoxidil, light therapy, or other hair growth treatments within 3 months.
I have NOT used medications affecting hair growth (e.g., finasteride, spironolactone, cyproterone acetate, 5‑alpha‑reductase inhibitors) or a GLP-1 within 6 months.
Study Design and Duration
This is a single‑center clinical study lasting approximately 20 weeks. If you agree to participate, you will be asked to attend study visits at the following time points: Baseline, and Weeks 2, 4, 8, 12, 16, and 20.